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Case of the Month #175: Intracranial Blastomycosis
Andrew D. Scott, MD*, Anita Dhir, MD, FRCP(C)
Department of Medical Imaging, Royal University Hospital, Saskatoon, Saskatchewan, CanadaClinical Presentation
A 27-year-old man from Ontario was referred to the
neurology service for a 2-month history of left-sided head-
ache, slurred speech, and limp. Results of a neurologic
examination revealed increased tone on the right, as well as
right-sided weakness and clonus of the right ankle reflex.
Contrast-enhanced computed tomography (CT) of the head
(Figures 1 and 2) was performed after a noncontrast study
revealed mass lesions in the left cerebral hemisphere and left
posterior fossa. A recent chest radiograph (Figure 3) was also
available at the time of the CT study.Diagnosis
Blastomyces dermatidis brain abscesses.Radiologic Findings
There is a complex appearing, heterogenous mass
lesion that involves the basal ganglia on the left, extending
anteriorly to involve the head of the caudate. The lesion
demonstrates regions of central and peripheral contrast
enhancement. There is a rightward midline shift and
subfalcine herniation. A left-sided, enhancing, posterior
fossa lesion appears to be extra-axial, which causes
a small amount of regional mass effect. There is oedem-
atous brain parenchyma around both lesions. The provided
chest radiograph shows some nonspecific apical fibrotic
changes.Key Words: Magnetic resonance; Computed tomography; Fungal
infection; Intracranial abscess.
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Bronchoscopy with bronchoalveolar lavage revealed yeast
cells with broad-based buds. Microscopy of fungal cultures
grown from these cells confirmed the diagnosis of B. der-
matidis. The patient responded well to antifungal treatment,
and follow-up CTs performed 2 months after initiation of
treatment showed marked improvement of the initial intra-
cranial lesions.
B. dermatidis is a dimorphic fungus found in the soil that
grows in yeast form at body temperature [1,2]. It is endemic
to the Mississippi and Ohio River valley areas of the United
States and, in Canada, in a particular area of northwestern
Ontario around Kenora [3e6]. Although the disease can be
subclinical, it most commonly presents with pulmonary
involvement after inhalation of the fungal spores, sometimes
mimicking a bacterial pneumonia in acute presentation
[2,7,8]. This initial infection may be cleared by the host,
develop into a severe respiratory illness with acute respira-
tory distress syndrome, or persist in a chronic form (some-
times mimicking tuberculosis (TB) or bronchogenic
carcinoma), with organisms remaining viable up to 3 years
later [2,9e11]. After the lungs, the next most commonly
involved organs are the skin and bones [12]. Central nervous
system (CNS) involvement in cases of systemic disease is
variably reported as occurring in 2.5%e10% of cases [7,13e
16]. Much higher rates of CNS involvement can be seen in
AIDS, in which CNS involvement can approach 40% [17].
Meningitis is usually named as the most common form of
CNS infection, with other presentations, including solitary or
multiple cerebral or cerebellar abscesses, granulomas, and
both cranial and spinal extradural abscesses, with associated
osteomyelitis [13,15,18,19]. In nearly all documented cases,
the lung is the source of hematogenous dissemination [2,20].
An interesting feature of the disease is that, unlike many
other fungal infections, it does not preferentially infect the
immunocompromised host [3,4,21,22]. Both the CT and
magnetic resonance imaging (MRI) appearances are
nonspecific [21]. On CT, parenchymal lesions can be hypo-,
iso-, or hyperdense [1,21,23]. Enhancement is variable, andll rights reserved.
Figure 1. Contrast-enhanced computed tomography axial image of the brain,
showing enhancing mass lesions in the left basal ganglia.
Figure 3. Posteroanterior chest radiograph, demonstrating apical fibrotic
changes in both lungs.
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enhancing [1,21,24]. Oedema is commonly seen around
intracranial lesions [21]. On MRI examination, the lesions
often appear as abscesses, sometimes with enhancing rims onFigure 2. Contrast-enhanced computed tomography axial image of the brain,
showing an enhancing extra-axial lesion in the posterior fossa.T1 gadolinium enhanced studies [16]. These blastomycotic
abscesses are often indistinguishable from other infectious
abscesses, as was the case in this patient (Figures 4 and 5)
[21]. Most granulomatous lesions are T2 hyperenhancing,
and T1 contrast enhancement has also been reported
[1,19,21]. Both unenhanced CT and gadolinium-enhanced
MRI may be normal in cases of meningoencephalitis,Figure 4. Sagittal postcontrast gradient T1-weighted image (204/5.16 [TR/
TE]), showing the intracranial lesions, demonstrating peripheral
enhancement.
Figure 5. Axial TSE T2 image at the level of the basal ganglia (3990/106
[TR/TE]), showing the intracranial lesions.
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seen on MRI [20].
Lung involvement is also nonspecific, with appearances
that range from airspace disease to nodular masses,Figures 6. Axial contrast-enhanced computed tomography of the lung apices
on lung windows, showing spiculated fibrotic changes.interstitial disease, or cavitating lung lesions [24]. There
needs to be a high clinical suspicion for the disease, or signs
and symptoms will incorrectly be attributed to more common
infectious agents such as TB [8]. In this case, the apical lung
changes seen (Figures 3 and 6) had resulted in a working
diagnosis of TB before bronchioalveolar lavage. Commonly
seen CT features of disease in the chest include regions of
consolidation and pulmonary masses, with internal air
bronchograms [10].
Diagnosis is primarily by direct visualization of the
yeasts in sampled body fluids or tissue samples, with
culture providing further confirmation [12,25]. Serology
tests have thus far been of limited utility, although new
serologic tests promise to be much more useful in clinical
practice [7]. There is a commercial assay kit now available
for detection of B. dermatidis antigen in serum or urine
samples [7].
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